InvestorsHub Logo
Post# of 252455
Next 10
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 80227

Friday, 08/28/2009 12:56:39 AM

Friday, August 28, 2009 12:56:39 AM

Post# of 252455
Biolex taps Cook Pharmica to manufacture Locteron for phase-3 trials (and presumably for commercialization if the phase-3 trials are successful):

http://finance.yahoo.com/news/Biolex-Therapeutics-Selects-iw-3953994604.html?x=0&.v=1

Locteron is a long-acting interferon alpha for HCV derived from transgenic plants.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.